Crinetics Pharmaceuticals Files 8-K on Governance Changes

Ticker: CRNX · Form: 8-K · Filed: Apr 4, 2025 · CIK: 1658247

Crinetics Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyCrinetics Pharmaceuticals, Inc. (CRNX)
Form Type8-K
Filed DateApr 4, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: governance, executive-compensation, board-changes

Related Tickers: CRNX

TL;DR

CRNX board shakeup and comp changes filed. Watch for new strategy.

AI Summary

On April 1, 2025, Crinetics Pharmaceuticals, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing indicates a shift in corporate governance and potential adjustments to how key personnel are compensated.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, financial priorities, or potential future performance.

Risk Assessment

Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future company direction and performance.

Key Players & Entities

  • Crinetics Pharmaceuticals, Inc. (company) — Registrant
  • April 01, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of Incorporation
  • San Diego, California (location) — Principal Executive Offices

FAQ

What specific changes were made to the board of directors?

The filing indicates 'Departure of Directors or Certain Officers; Election of Directors' as an item of information, suggesting changes to the board composition.

What are the details of the new compensatory arrangements?

The filing lists 'Compensatory Arrangements of Certain Officers' as an item of information, indicating that details regarding executive compensation have been updated or introduced.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on April 01, 2025.

What is the principal business address of Crinetics Pharmaceuticals, Inc.?

The principal executive offices are located at 6055 Lusk Boulevard, San Diego, California, 92121.

What is the SIC code for Crinetics Pharmaceuticals, Inc.?

The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 4, 2025 regarding Crinetics Pharmaceuticals, Inc. (CRNX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.